Semaglutide 10 mg
This lot was tested by PeptideVerify on 19 Aug 2026. Purity was measured by RP-HPLC, 220 nm. The signed report is reproduced below; the figures on this page are transcribed from it.
- Batch number
- BK-26-0024
- Compound
- Semaglutide 10 mg
- Tested
- 19 Aug 2026
- Laboratory
- PeptideVerify
- Purity
- 98.35 % (RP-HPLC, 220 nm)
- Purity, RP-HPLC, 220 nm
- 98.35 %
- Tested
- 19 Aug 2026
- Laboratory
- PeptideVerify
What this certificate shows
Purity 98.35 %. Reversed-phase HPLC separates the contents of the vial by how they interact with the column, and a UV detector measures each peak. 98.35 % of the detected material in lot BK-26-0024 is the target peptide, Semaglutide 10 mg; the remaining 1.65 % is made up of closely related sequences and synthesis by-products. Purity describes what the peptide portion is, not how much powder is in the vial.
How each figure is measured, and the limits a lot must meet before release, are set out in our testing methods. For in-vitro laboratory research only.